Cargando…
Humanized Anti-RGMa Antibody Treatment Promotes Repair of Blood-Spinal Cord Barrier Under Autoimmune Encephalomyelitis in Mice
The lack of established biomarkers which reflect dynamic neuropathological alterations in multiple sclerosis (MS) makes it difficult to determine the therapeutic response to the tested drugs and to identify the key biological process that mediates the beneficial effect of them. In the present study,...
Autores principales: | Hirata, Takeshi, Itokazu, Takahide, Sasaki, Atsushi, Sugihara, Fuminori, Yamashita, Toshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241446/ https://www.ncbi.nlm.nih.gov/pubmed/35784362 http://dx.doi.org/10.3389/fimmu.2022.870126 |
Ejemplares similares
-
RGMa inhibition promotes axonal growth and recovery after spinal cord injury
por: Hata, Katsuhiko, et al.
Publicado: (2006) -
The roles of RGMa-neogenin signaling in inflammation and angiogenesis
por: Fujita, Yuki, et al.
Publicado: (2017) -
Interleukin-17A regulates ependymal cell proliferation and functional recovery after spinal cord injury in mice
por: Miyajima, Hisao, et al.
Publicado: (2021) -
Activated Microglia Inhibit Axonal Growth through RGMa
por: Kitayama, Mari, et al.
Publicado: (2011) -
RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells
por: Tang, Shi, et al.
Publicado: (2022)